Progress in the Diagnosis and Treatment of Pulmonary Carcinoids

Pulmonary carcinoids(PCs) is a well differentiated, low-grade pulmonary neuroendocrine tumor. Compared with common lung cancer and other pulmonary neuroendocrine tumors, PCs have different pathological features, clinical manifestations and treatment methods. Treatment of bronchial carcinoids is not simple owing to intricacy of symptomatic presentation and heterogeneity of disease biology. Successful treatment of patients requires a multimodality approach. Resection is curative in the majority of patients with localized tumors and adjuvant treatment is not routinely recommended. Multiple options of systemic therapy exist for patients with an advanced disease. This paper reviews the progress in the diagnosis and treatment of PCs in recent years to standardize the diagnosis and treatment of PCs and benefit more patients.